Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $8.97 billion. The enterprise value is $4.65 billion.
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, before market open.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 301.18 million shares outstanding. The number of shares has increased by 1.94% in one year.
| Current Share Class | 265.59M |
| Shares Outstanding | 301.18M |
| Shares Change (YoY) | +1.94% |
| Shares Change (QoQ) | +16.42% |
| Owned by Insiders (%) | 5.04% |
| Owned by Institutions (%) | 55.51% |
| Float | 246.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 29.09 |
| PS Ratio | 0.67 |
| Forward PS | 0.47 |
| PB Ratio | 5.35 |
| P/TBV Ratio | 5.39 |
| P/FCF Ratio | 3.21 |
| P/OCF Ratio | 3.16 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 116.86, with an EV/FCF ratio of 1.66.
| EV / Earnings | n/a |
| EV / Sales | 0.35 |
| EV / EBITDA | 116.86 |
| EV / EBIT | 438.40 |
| EV / FCF | 1.66 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.09 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 8.76 |
| Debt / FCF | 0.17 |
| Interest Coverage | 0.62 |
Financial Efficiency
Return on equity (ROE) is -2.62% and return on invested capital (ROIC) is 0.58%.
| Return on Equity (ROE) | -2.62% |
| Return on Assets (ROA) | 0.09% |
| Return on Invested Capital (ROIC) | 0.58% |
| Return on Capital Employed (ROCE) | 0.49% |
| Weighted Average Cost of Capital (WACC) | 16.65% |
| Revenue Per Employee | $5.77M |
| Profits Per Employee | -$17,105 |
| Employee Count | 2,305 |
| Asset Turnover | 1.76 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $12.65 million in taxes.
| Income Tax | 12.65M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.24% in the last 52 weeks. The beta is 2.39, so Oscar Health's price volatility has been higher than the market average.
| Beta (5Y) | 2.39 |
| 52-Week Price Change | +55.24% |
| 50-Day Moving Average | 22.75 |
| 200-Day Moving Average | 17.62 |
| Relative Strength Index (RSI) | 67.65 |
| Average Volume (20 Days) | 7,674,850 |
Short Selling Information
The latest short interest is 17.99 million, so 5.97% of the outstanding shares have been sold short.
| Short Interest | 17.99M |
| Short Previous Month | 24.41M |
| Short % of Shares Out | 5.97% |
| Short % of Float | 7.29% |
| Short Ratio (days to cover) | 2.13 |
Income Statement
In the last 12 months, Oscar Health had revenue of $13.30 billion and -$39.43 million in losses. Loss per share was -$0.15.
| Revenue | 13.30B |
| Gross Profit | 2.31B |
| Operating Income | 10.61M |
| Pretax Income | -26.74M |
| Net Income | -39.43M |
| EBITDA | 39.79M |
| EBIT | 10.61M |
| Loss Per Share | -$0.15 |
Full Income StatementBalance Sheet
The company has $6.80 billion in cash and $482.24 million in debt, giving a net cash position of $4.32 billion or $14.35 per share.
| Cash & Cash Equivalents | 6.80B |
| Total Debt | 482.24M |
| Net Cash | 4.32B |
| Net Cash Per Share | $14.35 |
| Equity (Book Value) | 1.67B |
| Book Value Per Share | 5.57 |
| Working Capital | 636.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.84 billion and capital expenditures -$36.14 million, giving a free cash flow of $2.80 billion.
| Operating Cash Flow | 2.84B |
| Capital Expenditures | -36.14M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 371.12M |
| Free Cash Flow | 2.80B |
| FCF Per Share | $9.29 |
Full Cash Flow StatementMargins
Gross margin is 17.39%, with operating and profit margins of 0.08% and -0.30%.
| Gross Margin | 17.39% |
| Operating Margin | 0.08% |
| Pretax Margin | -0.20% |
| Profit Margin | -0.30% |
| EBITDA Margin | 0.30% |
| EBIT Margin | 0.08% |
| FCF Margin | 21.04% |